Omega Therapeutics Inc (NASDAQ:OMGA) currently has a daily average trading volume of 635.47K but it saw 12520685 shares traded in last market. With a market cap of 7.64M USD, the company’s current market price of $0.14 came falling about -8.00 while comparing to the previous closing price of $0.15. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.46 and as low as $0.14. In the recent trading on the day, stock has struck highest price mark of $0.1222 while lowest mark touched by it was $0.15.
Taking a look at 20-day trading activity of Omega Therapeutics Inc (OMGA) gives us an average price of $0.5204, while its current price level is -96.91% below from 52-week high level whereas it is -0.36% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.7287 while that of 200 days or SMA-200 reads an average of $1.4366. A closer look into the stock’s movement over the week reveals that its volatility is standing at 55.47% during that period while stretching the period over a month that decreases to 26.18%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 19.58 which implies that the stock is in oversold territory.
Jefferies issued its recommendations for the stock as it resumed the price target for the stock in the range of between $18 and $15.
Over the week, OMGA’s stock price is moving -71.55% down while it is -83.57% when we observe its performance for the past one month. Year-to-date it is -81.49% down and over the past year, the stock is showing a downside performance of -96.03%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.25 while estimate for next year EPS is -1.17. In next quarter, company is expected to be making quarterly sales of $450k as analysts are expecting the sales for current fiscal year at $7.61M and seeing the company making $1.35M in sales next year. Moreover, analysts are in estimates of $537.5k for current-quarter revenue.
Currently, Omega Therapeutics Inc’s total number of outstanding shares is 55.16M with 1.62% of that held by the insiders while 90.43% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -59.06% and return on equity (ROE) at -166.90%. Stock’s beta reads 1.70. Stock has a price to book (P/B) ratio of 0.66 while price to sale or P/S ratio amounts to 0.94. Its return on asset (ROA) is -39.45% on average.
